Michael P. Samar - 25 May 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role: Director
Signature: /s/ Alexander Hieu Nguyen, Attorney-in-Fact for Michael P. Samar
Issuer symbol: UBX
Transactions as of: 25 May 2022
Net transactions value: $0
Form type: 4
Filing time: 26 May 2022, 17:19:25 UTC
Previous filing: 31 Mar 2022
Next filing: 27 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UBX	Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	25 May 2022	Common Stock	50,000	$0.7600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 36-month period commencing on May 25, 2022 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Content

Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 36-month period commencing on May 25, 2022 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.